2-Methanesulfonylamino-benzoic acid → HCID 66975314, 화합물
반응식
[NH2:1][CH2:2][C@H:3]1[C@H:9]([C:10]2[CH:15]=[CH:14][C:13]([Cl:16])=[C:12]([F:17])[CH:11]=2)[O:8][CH2:7][CH2:6][N:5](C(OC(C)(C)C)=O)[CH2:4]1.[CH3:25][S:26]([NH:29][C:30]1[CH:38]=[CH:37][CH:36]=[CH:35][C:31]=1[C:32](O)=[O:33])(=[O:28])=[O:27]>>[ClH:16].[Cl:16][C:13]1[CH:14]=[CH:15][C:10]([C@@H:9]2[O:8][CH2:7][CH2:6][NH:5][CH2:4][C@H:3]2[CH2:2][NH:1][C:32](=[O:33])[C:31]2[CH:35]=[CH:36][CH:37]=[CH:38][C:30]=2[NH:29][S:26]([CH3:25])(=[O:28])=[O:27])=[CH:11][C:12]=1[F:17]참가 물질
3
실험 절차
Using tert-butyl (6R,7R)-6-(aminomethyl)-7-(4-chloro-3-fluorophenyl)-1,4-oxazepane-4-carboxylate and 2-[(methylsulfonyl)amino]benzoic acid, and by a method similar to that of Example 39, the title compound was obtained.
출처 및 근거
- ORD 기록
- ord-b9625740d4584a449b5c15196b419304
- 출처 데이터셋
- uspto-grants-2014_05
- 특허 번호